These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6186840)

  • 1. Chronic relapsing experimental autoimmune encephalomyelitis. Ultrastructure of the central nervous system of animals treated with combinations of myelin components.
    Raine CS; Traugott U
    Lab Invest; 1983 Mar; 48(3):275-84. PubMed ID: 6186840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids.
    Moore GR; Traugott U; Farooq M; Norton WT; Raine CS
    Lab Invest; 1984 Oct; 51(4):416-24. PubMed ID: 6207382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
    Raine CS; Moore GR; Hintzen R; Traugott U
    Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
    Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
    Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic-relapsing experimental autoimmune encephalomyelitis. Myelin basic protein induces suppression of blastogenesis during remissions but not during exacerbations.
    Lyman WD; Brosnan CF; Raine CS
    J Neuroimmunol; 1985; 7(5-6):345-53. PubMed ID: 2579093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse.
    Brown A; McFarlin DE; Raine CS
    Lab Invest; 1982 Feb; 46(2):171-85. PubMed ID: 7062721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of immune-mediated demyelination by lipid haptens.
    Raine CS; Traugott U; Farooq M; Bornstein MB; Norton WT
    Lab Invest; 1981 Aug; 45(2):174-82. PubMed ID: 6167795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic relapsing necrotizing encephalomyelitis produced by myelin basic protein in mice.
    Moore GR; McCarron RM; McFarlin DE; Raine CS
    Lab Invest; 1987 Aug; 57(2):157-67. PubMed ID: 2441138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system.
    Prineas J; Raine CS; Wísniewski H
    Lab Invest; 1969 Dec; 21(6):472-83. PubMed ID: 5356782
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic relapsing experimental autoimmune encephalomyelitis. treatment with combinations of myelin components promotes clinical and structural recovery.
    Traugott U; Stone SH; Raine CS
    J Neurol Sci; 1982 Oct; 56(1):65-73. PubMed ID: 6183403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic remitting-relapsing experimental allergic encephalomyelitis induced in monkeys with homologous myelin basic protein.
    Shaw CM; Alvord EC; Hruby S
    Ann Neurol; 1988 Dec; 24(6):738-48. PubMed ID: 2462850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis.
    Liu X; Yao DL; Bondy CA; Brenner M; Hudson LD; Zhou J; Webster HD
    Mol Cell Neurosci; 1994 Oct; 5(5):418-30. PubMed ID: 7529631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity.
    Willenborg DO; Staykova MA; Miyasaka M
    J Immunol; 1996 Sep; 157(5):1973-80. PubMed ID: 8757317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis.
    Lublin FD
    J Clin Lab Immunol; 1984 Apr; 13(4):179-82. PubMed ID: 6204053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent experimental allergic encephalomyelitis in the Lewis rat.
    McFarlin DE; Blank SE; Kibler RF
    J Immunol; 1974 Aug; 113(2):712-5. PubMed ID: 4136044
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic relapsing experimental allergic encephalomyelitis in strain 13 guinea pigs; presence of myelin basic protein in the local tissue long after the immunization.
    Tabira T; Itoyama Y; Kuroiwa Y
    Jpn J Exp Med; 1982 Jun; 52(3):131-7. PubMed ID: 6182318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental allergic encephalomyelitis in mice: encephalitogenicity of mouse central myelin basic proteins.
    Rauch HC; Katar M; Montgomery IN
    Eur J Immunol; 1981 Jul; 11(7):545-9. PubMed ID: 6169533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction.
    O'Brien NC; Charlton B; Cowden WB; Willenborg DO
    J Immunol; 1999 Dec; 163(12):6841-7. PubMed ID: 10586085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
    Racke MK; Burnett D; Pak SH; Albert PS; Cannella B; Raine CS; McFarlin DE; Scott DE
    J Immunol; 1995 Jan; 154(1):450-8. PubMed ID: 7527821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.